Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, And Amphetamine Sulfate Capsule, Extended Release
Product Images NDC 66993-596

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, And Amphetamine Sulfate (NDC 66993-596). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Prasco Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Adderall 01)

The text describes mean plasma concentrations of Dextroamphetamine and Levamphetamine in ng/mL for different dosages at various intervals of time, represented in a graph. The dosages include MAS-ER 20 mg ad, ADDERALL® 10 mg bid, and T MAS-ER 20mg qd. The time intervals are shown in hours, ranging from 12 to 24.*

FDA Label Image

Principal Display Panel (5 mg Capsule Bottle Label)

This is a medication called Dextroamphetamine Saccharate which is a mixture of different salts to produce an extended-release capsule used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. The medication guide must be dispensed by the pharmacist for the patient. There are 100 Capsules in a prescription.*

FDA Label Image

Principal Display Panel (10 mg Capsule Bottle Label)

This is a medication description for a 10mg extended-release capsule containing Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate. These active ingredients belong to the "Mixed Salts of A Single-Entity Amphetamine Product" category. The product contains 100 capsules and is available by prescription only. The pharmacist should refer to the attached E225 label for dispensing information.*

FDA Label Image

Principal Display Panel (15 mg Capsule Bottle Label)

This is a description of a medication named NDC 66993-596.02. It includes information about the type of drug, its dose (5mg), and what it is used for (treating various conditions). The medication comes in a container that should be stored at room temperature, and there are detailed instructions included in the package insert. Pharmacies should dispense the medication with an attached medication guide. The manufacturer is Prasco, and the medication is only available with a prescription (Rx only).*

FDA Label Image

Principal Display Panel (20 mg Capsule Bottle Label)

This is a medication with the NDC code 66093-597-02. It contains a combination of Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate. It is an Extended-Release capsule with a strength of 20mg. The medication guide is attached and should be dispensed with the medication. It should be stored at room temperature, and each capsule contains different strength of the constituents. The package insert should be consulted for complete information.*

FDA Label Image

Principal Display Panel (25 mg Capsule Bottle Label)

This appears to be a prescription drug label for a medication with the brand name "DO G650". It is an extended-release capsule containing a combination of different salts of dextroamphetamine and amphetamine. The exact dosage is not mentioned, but it comes in both 25 mg and 100 capsule packages and is available only with a prescription (Rx only). The label also includes the name of a pharmaceutical company called PRASCO.*

FDA Label Image

Principal Display Panel (30 mg Capsule Bottle Label)

This is a description of a prescription medication. The medication is a combination of different salts of amphetamine, including dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate, and is designed as an extended-release capsule with a strength of 30 mg. The medication contains a medication guide and should be dispensed in a light-resistant container per USP guidelines. The total amount of amphetamine base equivalence is 18.8 mg per capsule. The medication is packaged with 100 capsules and is available only by prescription.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.